← back to search

Jie Liu

Chinese Academy of Tropical Agricultural Sciences · CN
Area of research
Cancer Research · Computational Theory and Mathematics
Research interest
Research interests include MicroRNA in disease regulation, Computational Drug Discovery Methods, Circular RNAs in diseases, and Cancer-related molecular mechanisms research.
h-index
47
citations
8,568
works
293
NIH funding
primary concept
email

Recent publications

Deciphering the pharmacological mechanisms of Weiweisu decoction in chronic atrophic gastritis: Insights from network pharmacology, molecular dynamics, and in vivo validation
Medicine 2025cited by 0position: middledoi
Group decision on rationalizing disease analysis using novel distance measure on Pythagorean fuzziness
Complex & Intelligent Systems 2024cited by 62position: middledoi
Therapeutic efficacy of ECs Foxp1 targeting Hif1α-Hk2 glycolysis signal to restrict angiogenesis
Redox Biology 2024cited by 14position: middledoi
Identification and Functional Analysis of circRNAs during Goat Follicular Development
International Journal of Molecular Sciences 2024cited by 10position: firstdoi
Review of machine learning and deep learning models for toxicity prediction.
2023cited by 47position: contributordoi
Biotransformation of bisphenol A in vivo and in vitro by laccase-producing Trametes hirsuta La-7: Kinetics, products, and mechanisms
Environmental Pollution 2023cited by 26position: firstdoi
Machine learning and deep learning for brain tumor MRI image segmentation.
2023cited by 20position: contributordoi
Three-Dimensional Structural Insights Have Revealed the Distinct Binding Interactions of Agonists, Partial Agonists, and Antagonists with the µ Opioid Receptor.
2023cited by 11position: contributordoi
Developing a SARS-CoV-2 main protease binding prediction random forest model for drug repurposing for COVID-19 treatment.
2023cited by 10position: contributordoi
Exosome-shuttled miR-126 mediates ethanol-induced disruption of neural crest cell-placode cell interaction by targeting SDF1
Toxicological Sciences 2023cited by 8position: middledoi
Analyzing 3D structures of the SARS-CoV-2 main protease reveals structural features of ligand binding for COVID-19 drug discovery.
2023cited by 5position: contributordoi
Machine Learning Models for Predicting Cytotoxicity of Nanomaterials.
2022cited by 38position: contributordoi
The novel importance of miR-143 in obesity regulation
International Journal of Obesity 2022cited by 21position: firstdoi
Dexamethasone and potassium canrenoate alleviate hyperalgesia by competitively regulating IL‐6/JAK2/STAT3 signaling pathway during inflammatory pain in vivo and in vitro
Immunity Inflammation and Disease 2022cited by 18position: firstdoi
Deep Learning Models for Predicting Gas Adsorption Capacity of Nanomaterials.
2022cited by 17position: contributordoi
Free energy perturbation–based large-scale virtual screening for effective drug discovery against COVID-19
The International Journal of High Performance Computing Applications 2022cited by 15position: middledoi
Machine learning models for rat multigeneration reproductive toxicity prediction.
2022cited by 13position: contributordoi
Machine learning driven by environmental covariates to estimate high-resolution PM2.5 in data-poor regions
PeerJ 2022cited by 11position: middledoi
Machine Learning Models for Predicting Liver Toxicity.
2022cited by 10position: contributordoi
Rhodiola pre-conditioning reduces exhaustive exercise-induced myocardial injury of insulin resistant mice
Scientific Reports 2022cited by 2position: middledoi
The Emerging Role of BDNF/TrkB Signaling in Cardiovascular Diseases
Life 2021cited by 70position: middledoi
Nanomaterial Databases: Data Sources for Promoting Design and Risk Assessment of Nanomaterials.
2021cited by 28position: contributordoi
Advances in cell death - related signaling pathways in acute-on-chronic liver failure
Clinics and Research in Hepatology and Gastroenterology 2021cited by 10position: middledoi
Elucidation of Agonist and Antagonist Dynamic Binding Patterns in ER-α by Integration of Molecular Docking, Molecular Dynamics Simulations and Quantum Mechanical Calculations.
2021cited by 8position: contributordoi
Identification of Epidemiological Traits by Analysis of SARS-CoV-2 Sequences.
2021cited by 4position: contributordoi
Identification of key miRNA signature and pathways involved in multiple myeloma by integrated bioinformatics analysis
Figshare 2021cited by 1position: middledoi
MiR-125b-2 knockout increases high-fat diet-induced fat accumulation and insulin resistance
Scientific Reports 2020cited by 20position: middledoi
Displacement of peritoneal end of a shunt tube to pleural cavity: A case report
World Journal of Clinical Cases 2020cited by 2position: firstdoi
MicroRNA-365 suppressed cell proliferation and migration via targeting PAX6 in glioblastoma.
PubMed 2019cited by 14position: middle
Selection of reference genes for miRNA quantitative PCR and its application in miR-34a/Sirtuin-1 mediated energy metabolism in Megalobrama amblycephala
Fish Physiology and Biochemistry 2019cited by 12position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Huixiao Hong · National Center for Advancing Translational Sciences9 papers (2021–2023) · 3 papers (2023–2023)Wenjing Guo · National Center for Toxicological Research3 papers (2023–2023)Md Kamrul Hasan Khan · Mayo Clinic3 papers (2023–2023)Xiaohui Guo · Shandong University2 papers (2013–2014)Qingsong Li · Dalian Ocean University2 papers (2017–2019)Zhigang Zhao · Hebei Medical University2 papers (2013–2014)Xiang‐Fei Li · Nanjing Agricultural University2 papers (2018–2019)Yu Tian · Jiangsu University2 papers (2017–2019)Huajuan Shi · Nanjing Agricultural University2 papers (2018–2019)Shaoyu Chen · University of Illinois Urbana-Champaign2 papers (2015–2023)Dalong Zhu · Nanjing Medical University2 papers (2013–2014)Qianyun Xi · South China Agricultural University2 papers (2020–2022)Caiqun Bie · Guangzhou University of Chinese Medicine2 papers (2021–2025)Yongri Zheng · Harbin Medical University2 papers (2017–2019)Juming Lu · Chinese PLA General Hospital2 papers (2013–2014)Xiaoming Xu · China Pharmaceutical University2 papers (2022–2022)Weiping Jia · The Fourth People's Hospital2 papers (2013–2014)Jianping Weng · University of Science and Technology of China2 papers (2013–2014)Linong Ji · SAIC-GM (China)2 papers (2013–2014)